JP2009539877A5 - - Google Patents

Download PDF

Info

Publication number
JP2009539877A5
JP2009539877A5 JP2009514546A JP2009514546A JP2009539877A5 JP 2009539877 A5 JP2009539877 A5 JP 2009539877A5 JP 2009514546 A JP2009514546 A JP 2009514546A JP 2009514546 A JP2009514546 A JP 2009514546A JP 2009539877 A5 JP2009539877 A5 JP 2009539877A5
Authority
JP
Japan
Prior art keywords
diabetes
group
phenylacetic acid
composition
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009514546A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009539877A (ja
JP5252585B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/070691 external-priority patent/WO2007146768A2/en
Publication of JP2009539877A publication Critical patent/JP2009539877A/ja
Publication of JP2009539877A5 publication Critical patent/JP2009539877A5/ja
Application granted granted Critical
Publication of JP5252585B2 publication Critical patent/JP5252585B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009514546A 2006-06-09 2007-06-08 代謝障害の治療のための化合物 Expired - Fee Related JP5252585B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US80433606P 2006-06-09 2006-06-09
US60/804,336 2006-06-09
PCT/US2007/070691 WO2007146768A2 (en) 2006-06-09 2007-06-08 Compounds for the treatment of metabolic disorders

Publications (3)

Publication Number Publication Date
JP2009539877A JP2009539877A (ja) 2009-11-19
JP2009539877A5 true JP2009539877A5 (enExample) 2011-07-21
JP5252585B2 JP5252585B2 (ja) 2013-07-31

Family

ID=38832700

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009514546A Expired - Fee Related JP5252585B2 (ja) 2006-06-09 2007-06-08 代謝障害の治療のための化合物

Country Status (12)

Country Link
US (1) US20100234464A1 (enExample)
EP (1) EP2026659A4 (enExample)
JP (1) JP5252585B2 (enExample)
KR (1) KR101391905B1 (enExample)
CN (1) CN101466266A (enExample)
AU (1) AU2007257854B2 (enExample)
CA (1) CA2654530A1 (enExample)
IL (1) IL195392A0 (enExample)
MX (1) MX2008015640A (enExample)
NZ (1) NZ573031A (enExample)
WO (1) WO2007146768A2 (enExample)
ZA (1) ZA200809774B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009525982A (ja) * 2006-02-02 2009-07-16 ウェルスタット セラピューティクス コーポレイション 代謝障害の治療のための化合物
WO2009091732A1 (en) * 2008-01-15 2009-07-23 Wellstat Therapeutics Corporation Compounds for the treatment of metabolic disorders
US8829058B2 (en) * 2008-03-13 2014-09-09 Wellstat Therapeutics Corporation Compounds and method for reducing uric acid
RU2573933C1 (ru) 2014-08-21 2016-01-27 Дафот Энтерпрайсис Лимитед Пептид для лечения сахарного диабета 2-го типа и его осложнений
EP4548898A1 (en) 2022-07-01 2025-05-07 The University of Tokyo Body surface ulcer healing promoting device

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1695716A2 (en) * 2000-12-26 2006-08-30 Sankyo Company, Limited Medicinal compositions containing diuretics and insulin sensitizers
RU2341513C2 (ru) * 2001-06-12 2008-12-20 Веллстат Терапьютикс Корпорейшн Соединения для лечения метаболических заболеваний
CA2502297C (en) * 2002-11-01 2011-12-13 Wellstat Therapeutics Corporation Compounds for the treatment of metabolic disorders
ES2530235T3 (es) * 2003-02-13 2015-02-27 Wellstat Therapeutics Corporation Compuestos para el tratamiento de trastornos metabólicos
ES2353601T3 (es) * 2003-04-15 2011-03-03 Wellstat Therapeutics Corporation Compuestos para el tratamiento de trastornos metabólicos.
CN1777576A (zh) * 2003-04-22 2006-05-24 维尔斯达医疗公司 用于治疗代谢紊乱的化合物
CA2522738C (en) * 2003-04-30 2011-11-08 Wellstat Therapeutics Corporation Compounds for the treatment of metabolic disorders
MXPA06001963A (es) * 2003-08-20 2006-05-31 Wellstat Therapeutics Corp Compuestos para el tratamiento de trastornos metabolicos.
AU2007208127A1 (en) * 2006-01-25 2007-08-02 Wellstat Therapeutics Corporation Compounds for the treatment of metabolic disorders
US7820721B2 (en) * 2006-01-25 2010-10-26 Wellstat Therapeutics Corporation Compounds for the treatment of metabolic disorders

Similar Documents

Publication Publication Date Title
JP2009537559A5 (enExample)
JP5241228B2 (ja) 非ステロイド性抗炎症薬、鬱血除去薬および鎮静作用の少ない抗ヒスタミン薬を含む多層錠
JP2009531280A5 (enExample)
KR101860120B1 (ko) 글루코키나아제 활성화제와 병용되는 메트포르민의 용도, 및 메트포르민과 글루코키나아제 활성화제를 포함하는 조성물
JPH01503539A (ja) 非鎮静抗ヒスタミン薬を含んでなる咳／風邪用混合物
TW201136916A (en) New uses
JP2009528275A5 (enExample)
TW200406204A (en) Combination of organic compounds
RU2005128501A (ru) Соединение для лечения метаболических расстройств
TW200305415A (en) Combination of organic compounds
CA2521621A1 (en) Compounds for the treatment of metabolic disorders
JP2006514100A (ja) 徐放性ｌ−アルギニン製剤並びに製造方法および使用方法
CA2522738A1 (en) Compounds for the treatment of metabolic disorders
JP2006524252A5 (enExample)
CA2502297A1 (en) Compounds for the treatment of metabolic disorders
JP5490409B2 (ja) スタチンおよびメチルニコチンアミド誘導体を含んでなるリポ蛋白質異常の処置用調剤
CA2521589A1 (en) Compounds for the treatment of metabolic disorders
CN1777417B (zh) PPARα激动剂和二甲双胍降低血清甘油三酯的用途
EP1772149A1 (en) Drug for prevention or treatment of diabetes
JP2025160480A (ja) 不眠症を治療するためのレンボレキサントの使用
JP2009524686A5 (enExample)
EA015483B1 (ru) ПРИМЕНЕНИЕ ИНГИБИТОРА p38 КИНАЗЫ ДЛЯ ЛЕЧЕНИЯ ПСИХИАТРИЧЕСКИХ РАССТРОЙСТВ
MX2008015640A (es) Compuestos para el tratamiento de trastornos metabolicos.
US9433602B2 (en) Combination and composition for treating obesity
CN1414847A (zh) 含吡喹酮的缓释抗蠕虫组合物